4//SEC Filing
Henderson Molly 4
Accession 0001209191-23-054355
CIK 0001783183other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:55 PM ET
Size
8.8 KB
Accession
0001209191-23-054355
Insider Transaction Report
Form 4
Henderson Molly
CFO and CBO
Transactions
- Sale
Common Stock
2023-11-01$7.80/sh−811$6,326→ 116,869 total - Award
Common Stock
2023-11-01+22,500→ 117,680 total - Sale
Common Stock
2023-11-01$8.95/sh−11,681$104,545→ 105,188 total
Holdings
- 1,134.27(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Represents shares earned with respect to a performance stock unit award granted on January 19, 2023 that contained a performance-vesting requirement that was satisfied on November 1, 2023.
- [F2]Represents shares sold to satisfy tax withholding obligations upon the settlement of performance stock units.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001363812
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 4:55 PM ET
- Size
- 8.8 KB